“…In preparing a systematic review with Carlo Mengoli of the Department of Histology, Microbiology, and Medical Biotechnology, University of Padua, Padua, Italy and Mario Cruciani from the Centre of Preventive Medicine, HIV Outpatient Clinic, Verona, Italy based on the review of Boudewijns et al [5], we identifi ed 16 prospective cohort studies of consecutive patients at high risk for invasive aspergillosis akin to phase 2 drug studies [3,6-8,9•,10,11,12•, [13][14][15][16][17][18][19][20]. All compared the results of PCR with the diagnosis made following the original defi nitions for invasive fungal disease proposed by the EORTC/MSG or, for studies reported before the publication of these criteria in 2002, comparable criteria as a reference standard [1].…”